Max Healthcare Institute Limited (NSE: MAXHEALTH)
India
· Delayed Price · Currency is INR | Market Cap | 962.07B |
| Revenue (ttm) | 60.08B |
| Net Income (ttm) | 10.59B |
| Shares Out | n/a |
| EPS (ttm) | 10.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Aug 23, 2024 |
| Volume | 742,785 |
| Open | 1,009.00 |
| Previous Close | 999.85 |
| Day's Range | 994.10 - 1,009.00 |
| 52-Week Range | 599.15 - 1,118.00 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 6, 2024 |
About Max Healthcare Institute
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including advanced cardiac care, orthopaedics, oncology, renal sciences, neurosciences, minimal access metabolic and bariatric surgery, obstetrics, gynaecology, paediatrics, nephrology, and general surgery, as well as liver, heart, kidney, lung and bone marrow transplants. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to pa... [Read more]
Financial Performance
In 2023, Max Healthcare Institute's revenue was 54.06 billion, an increase of 18.49% compared to the previous year's 45.63 billion. Earnings were 10.58 billion, a decrease of -4.16%.
Financial StatementsNews
Max Healthcare Institute: Stock closes 16.69% below 52-week high, 70.50% above 52-week low
Max Healthcare Institute (NSE: MAXHEALTH) ended trading on November 17, 2024, at ₹1,006.25, reflecting a slight gain of 0.43%. The stock remains 16.69% below its 52-week high of ₹1,207.50 and 70.50% a...
Max Healthcare shares surge 2% after acquisition of Jaypee Healthcare for Rs 227 crore
Max Healthcare’s stock rose 2% in morning trade following the completion of its acquisition of Jaypee Healthcare Limited (JHL). On November 11, 2024, Max Healthcare finalized the purchase of JHL’s rem...
Max Healthcare completes 100% acquisition of Jaypee Healthcare for Rs 227 crore
In a significant development, Max Healthcare has announced the completion of its acquisition of Jaypee Healthcare Limited (JHL), achieving full ownership of the healthcare entity. This acquisition, wh...
Max Healthcare shares rise nearly 3%, emerge as top gainer in morning trade
Max Healthcare Institute shares rise nearly 3%, emerging as one of the top gainers this morning. The stock opened at ₹1,028 and reached an intraday high of ₹1,049.80 on the NSE, showing a 2.47% increa...
Major Block Trades Today: Mahindra & Mahindra ₹168.49 crore, PB Fintech ₹150.85 crore, Max Healthcare ₹95.05 crore
Several large block trades took place on the NSE today, involving major companies like Mahindra & Mahindra, Max Healthcare Institute, and PB Fintech. Here are the key details: Max Healthcare Institute...
Jaypee Infratech sells 63.65% stake in Jaypee Healthcare to Max Healthcare for ₹398 crore
Jaypee Infratech Limited has sold 63.65% of its equity stake in Jaypee Healthcare Limited (JHL) to Max Healthcare Institute Limited for a total amount of ₹398 crore. The sale was part of a proposal su...
Max Healthcare set to take over Jaypee hospitals
Max Healthcare plans to acquire a 64% stake in Jaypee Healthcare for Rs 1,660 crore, which includes the flagship 500-bed Jaypee Hospital in Noida. This strategic move aims to bolster medical infrastru...
Max Healthcare collaborates with Lakshdeep Group for turnaround and acquisition of controlling stake in Jaypee Healthcare
Max Healthcare Institute Ltd has recently informed exchanges that the company has signed a strategic collaboration agreement with Lakshdeep Group, the ultimate promoter group of Jaypee Healthcare Limi...
Max Healthcare shares surge 4% for second day in a row
Shares of Max Healthcare Institute jumped more than 4% in the morning trade for the second day in a row. In the exchange filing on Wednesday, the company shared, “The Board of Directors of ET Planners...